drug

Conversion to Antipsychotic Monotherapy

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
OTHER
Pre-approval / investigational in the US
Developed by Nathan Kline Institute for Psychiatric Research
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
OTHER

Indications

Trials

1
Conversion to Antipsychotic Monotherapy
NCT01368458—Terminated

KOLs & investigators

1
Joshua T Kantrowitz, MDKOL score 16

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Nathan Kline Institute for Psychiatric Research
company
trial
Conversion to Antipsychotic Monotherapy
NA
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
Schizoaffective Disorder
indication
KOL
Joshua T Kantrowitz, MD
KOL score 16
person